Senator Klobuchar says Mylan (MYL) incorrectly classified EpiPen as generic, citing letter to HHS - Bloomberg

September 7, 2016 3:32 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Senator Klobuchar says Mylan (NYSE: MYL) incorrectly classified EpiPen as generic, citing letter to HHS - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Short Sales, Trader Talk

Add Your Comment